Curaleaf Holdings, Inc. (CURLF) Financials
CURLF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2026 | 2.8 billion | 1.9 billion |
| June 30, 2026 | 2.8 billion | 1.9 billion |
| March 31, 2026 | 2.8 billion | 1.9 billion |
| Dec. 31, 2025 | 2.8 billion | 2.0 billion |
CURLF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2026 | 4.0 million | 14.0 million |
| June 30, 2026 | 13.0 million | 20.1 million |
| March 31, 2026 | 3.9 million | ? |
| Dec. 31, 2025 | 27.2 million | ? |
CURLF Net Income
No data available :(
CURLF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2026 | 92.4 million | 776.2 million | 299.0 million |
| June 30, 2026 | 107.0 million | 766.0 million | 297.7 million |
| March 31, 2026 | 106.5 million | 526.8 million | 434.4 million |
| Dec. 31, 2025 | 101.4 million | 512.0 million | 448.9 million |
CURLF Shares Outstanding
CURLF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2026 | 17.1 million | - | 131.0 million | 10.6 million |
| June 30, 2026 | 15.5 million | 449000 | 131.2 million | 16.4 million |
| March 31, 2026 | 16.7 million | - | 121.2 million | - |
| Dec. 31, 2025 | 15.8 million | - | 125.4 million | - |
CURLF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2026 | 352.7 million | 182.2 million |
| June 30, 2026 | 340.1 million | 170.2 million |
| March 31, 2026 | 319.7 million | 197.8 million |
| Dec. 31, 2025 | 338.2 million | 209.8 million |
CURLF Revenue by Segment
Graph available only for paid members. Upgrade to see it.
CURLF
Price: $7.59
52 week price:
Earnings Per Share: -0.36 USD
P/E Ratio: -6.33
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 2.6 billion